Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2026-01-22 @ 4:27 PM
Study NCT ID:
NCT00114166
Status:
COMPLETED
Last Update Posted:
2018-07-24
First Post:
2005-06-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Sponsor:
Gynecologic Oncology Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-01
Start Date Type:
None
Primary Completion Date:
2011-01
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2005-06-13
First Submit QC Date:
None
Study First Post Date:
2005-06-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-05-27
Results First Submit QC Date:
None
Results First Post Date:
2014-06-26
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-06-27
Last Update Post Date:
2018-07-24
Last Update Post Date Type:
ACTUAL